Prescribing restrictions for generic sildenafil removed

The Department of Health has removed restrictions requiring prescribers to endorse prescriptions for the generic erectile dysfunction drug sildenafil.

Restrictions on Viagra have been maintained as its price has not fallen. | SCIENCE PHOTO LIBRARY
Restrictions on Viagra have been maintained as its price has not fallen. | SCIENCE PHOTO LIBRARY

On 1st August, an amendment to the NHS Prescription of Drugs Regulations saw the removal of generic sildenafil from the selected list scheme (SLS), meaning that prescribers are no longer required to endorse prescriptions for the erectile dysfunction drug with 'SLS'.

The change was made following a significant reduction in the price of sildenafil after the expiry of patent protection for Viagra last year. The restrictions continue to apply to branded Viagra and certain other erectile dysfunction therapies such as alprostadil, avanafiltadalafil and vardenafil.

These drugs may be prescribed on the NHS only in certain circumstances, including for men with prostate cancer, kidney failure treated with dialysis or transplantation, spinal cord injury, diabetes, multiple sclerosis, Parkinson's disease, following radical pelvic surgery or prostatectomy, and through specialist services for men suffering severe distress because of impotence.

The generic drugs apomorphine hydrochloride, moxisylyte hydrochloride and thymoxamine hydrochloride have also been removed from the SLS list.

View Erectile dysfunction drug records

Follow MIMS on Twitter

Sign up for MIMS bulletins

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more